Market Closed -
Other stock markets
|
After market 07:08:31 am | |||
5.66 USD | -0.18% | 5.79 | +2.30% |
May. 01 | Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration | MT |
May. 01 | Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration | CI |
Financials (USD)
Sales 2024 * | 34.3M | Sales 2025 * | 24.82M | Capitalization | 465M |
---|---|---|---|---|---|
Net income 2024 * | -206M | Net income 2025 * | -242M | EV / Sales 2024 * | 6.21 x |
Net cash position 2024 * | 252M | Net cash position 2025 * | 95M | EV / Sales 2025 * | 14.9 x |
P/E ratio 2024 * |
-2.31
x | P/E ratio 2025 * |
-2.21
x | Employees | 265 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.68% |
Latest transcript on Editas Medicine, Inc.
1 day | -0.18% | ||
1 week | +5.40% | ||
Current month | +8.64% | ||
1 month | -15.77% | ||
3 months | -21.50% | ||
6 months | -31.89% | ||
Current year | -44.13% |
Managers | Title | Age | Since |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 22-05-31 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 23-05-16 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 21-09-02 |
David Scadden
BRD | Director/Board Member | 71 | 19-02-05 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 16-07-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.83% | 2 M€ | -25.75% | ||
0.13% | 2 M€ | -.--% | ||
0.09% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 5.66 | -0.18% | 1,492,893 |
24-05-03 | 5.67 | +0.89% | 1,613,699 |
24-05-02 | 5.62 | +2.74% | 1,664,383 |
24-05-01 | 5.47 | +4.99% | 2,617,619 |
24-04-30 | 5.21 | -2.98% | 1,467,552 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.13% | 465M | |
+22.81% | 46.81B | |
+47.07% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- EDIT Stock